Universe Pharmaceuticals Inc. Ordinary Shares
UPCUniverse Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development, manufacturing, and commercialization of innovative healthcare products, primarily focusing on pharmaceuticals and related healthcare solutions. Founded with an emphasis on expanding access to essential medicines, it aims to deliver innovative treatments across various therapeutic areas.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| May 17, 2004 | $0.33 | 2004-04-29 | 2004-05-03 |
| February 17, 2004 | $0.33 | 2004-01-29 | 2004-02-02 |
Dividends Summary
- Consistent Payer: Universe Pharmaceuticals Inc. Ordinary Shares has rewarded shareholders with 2 dividend payments over the past 0 years.
- Total Returned Value: Investors who held UPC shares during this period received a total of $0.67 per share in dividend income.
- Latest Payout: The most recent dividend of $0.33/share was paid 7921 days ago, on May 17, 2004.
- Dividend Growth: Since 2004, the dividend payout has grown by 0.0%, from $0.33 to $0.33.
Company News
Universe Pharmaceuticals INC, a Chinese pharmaceutical company, received a notification from Nasdaq that it is not in compliance with the minimum bid price requirement for continued listing. The company has 180 days to regain compliance by maintaining a closing bid price of at least $1.00 per share for 10 consecutive business days.
Shares of Fluor Corporation (NYSE: FLR) fell during Tuesday’s session following fourth-quarter results. Fluor posted adjusted earnings of 68 cents per share, beating market estimates of 57 cents per share. The company’s quarterly sales came in at $3.82 billion versus expectations of $4.11 billion. Fluor shares declined 7.7% to $38.84 on Tues...
Shares of Discover Financial Services (NYSE: DFS) shares rose sharply in today’s pre-market trading. Capital One Financial Corp (NYSE: COF) announced its plans to purchase Discover Financial Services, marking a pivotal $35.3 billion all-stock transaction. As per the terms of the deal, Discover shareholders are slated to receive 1.0192 shares o...
Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41. RxSight shares jumped 20% to $44.31 on Monday. Here are some other stocks moving in toda...
Jiangxi, China, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that the Company received a written notification (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) o...
